The current valuation score of Benitec Biopharma Inc is 8.53, ranking 116 out of 384 in the Biotechnology & Medical Research industry. Its current P/E ratio is -13.06, which is -255.81% below the recent high of 20.35 and -46.09% above the recent low of -19.08.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.